These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 2009533)

  • 41. Inhibition of tumor cell invasion by a highly conserved peptide sequence from the matrix metalloproteinase enzyme prosegment.
    Melchiori A; Albini A; Ray JM; Stetler-Stevenson WG
    Cancer Res; 1992 Apr; 52(8):2353-6. PubMed ID: 1313744
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Decreased expression of tissue inhibitor of metalloproteinases in metastatic tumor cells leading to increased levels of collagenase activity.
    Ponton A; Coulombe B; Skup D
    Cancer Res; 1991 Apr; 51(8):2138-43. PubMed ID: 1849044
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumor-associated trypsin participates in cancer cell-mediated degradation of extracellular matrix.
    Koivunen E; Ristimäki A; Itkonen O; Osman S; Vuento M; Stenman UH
    Cancer Res; 1991 Apr; 51(8):2107-12. PubMed ID: 2009530
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases.
    Alvarez OA; Carmichael DF; DeClerck YA
    J Natl Cancer Inst; 1990 Apr; 82(7):589-95. PubMed ID: 2156082
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protective role of transforming growth factor beta (TGF beta) in tumor-induced degradation of basement membranes.
    Pavelić K; Despot N; Levanat S; Casl T
    Biol Chem Hoppe Seyler; 1990 Aug; 371(8):687-92. PubMed ID: 2169765
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficient purification of TIMP-2 from culture medium conditioned by human hepatoma cell line, and its inhibitory effects on metalloproteinases and in vitro tumor invasion.
    Umenishi F; Umeda M; Miyazaki K
    J Biochem; 1991 Aug; 110(2):189-95. PubMed ID: 1662201
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibitory effect of delphinidin from Solanum melongena on human fibrosarcoma HT-1080 invasiveness in vitro.
    Nagase H; Sasaki K; Kito H; Haga A; Sato T
    Planta Med; 1998 Apr; 64(3):216-9. PubMed ID: 9581517
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A metalloproteinase inhibitor as an inhibitor of neovascularization.
    Moses MA; Langer R
    J Cell Biochem; 1991 Nov; 47(3):230-5. PubMed ID: 1724245
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of activator protein-1 binding activity and phosphatidylinositol 3-kinase pathway by nobiletin, a polymethoxy flavonoid, results in augmentation of tissue inhibitor of metalloproteinases-1 production and suppression of production of matrix metalloproteinases-1 and -9 in human fibrosarcoma HT-1080 cells.
    Sato T; Koike L; Miyata Y; Hirata M; Mimaki Y; Sashida Y; Yano M; Ito A
    Cancer Res; 2002 Feb; 62(4):1025-9. PubMed ID: 11861377
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alpha 2-macroglobulin and tissue inhibitor of metalloproteinases: collagenase inhibitors in human preovulatory ovaries.
    Curry TE; Mann JS; Estes RS; Jones PB
    Endocrinology; 1990 Jul; 127(1):63-8. PubMed ID: 1694500
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HT-1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix-associated serine protease inhibitor TFPI-2/33 kDa MSPI.
    Rao CN; Cook B; Liu Y; Chilukuri K; Stack MS; Foster DC; Kisiel W; Woodley DT
    Int J Cancer; 1998 May; 76(5):749-56. PubMed ID: 9610735
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation.
    Murphy AN; Unsworth EJ; Stetler-Stevenson WG
    J Cell Physiol; 1993 Nov; 157(2):351-8. PubMed ID: 7693724
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Functional analysis of matrix metalloproteinases and tissue inhibitors of metalloproteinases differentially expressed by variants of human HT-1080 fibrosarcoma exhibiting high and low levels of intravasation and metastasis.
    Partridge JJ; Madsen MA; Ardi VC; Papagiannakopoulos T; Kupriyanova TA; Quigley JP; Deryugina EI
    J Biol Chem; 2007 Dec; 282(49):35964-77. PubMed ID: 17895241
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumor cell invasion inhibited by TIMP-2.
    Albini A; Melchiori A; Santi L; Liotta LA; Brown PD; Stetler-Stevenson WG
    J Natl Cancer Inst; 1991 Jun; 83(11):775-9. PubMed ID: 1645772
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibitory effect of magnolol and honokiol from Magnolia obovata on human fibrosarcoma HT-1080. Invasiveness in vitro.
    Nagase H; Ikeda K; Sakai Y
    Planta Med; 2001 Nov; 67(8):705-8. PubMed ID: 11731909
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A microfluidic device for characterizing the invasion of cancer cells in 3-D matrix.
    Liu T; Li C; Li H; Zeng S; Qin J; Lin B
    Electrophoresis; 2009 Dec; 30(24):4285-91. PubMed ID: 20013914
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is there a role for metalloproteases in chick neural retina development?
    Sheffield JB
    Matrix Suppl; 1992; 1():391-2. PubMed ID: 1480067
    [No Abstract]   [Full Text] [Related]  

  • 58. The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis.
    Ray JM; Stetler-Stevenson WG
    Eur Respir J; 1994 Nov; 7(11):2062-72. PubMed ID: 7533104
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dissociation of tissue inhibitor of metalloproteinases (TIMP) from enzyme complexes yields fully active inhibitor.
    Murphy G
    Matrix Suppl; 1992; 1():323-4. PubMed ID: 1480052
    [No Abstract]   [Full Text] [Related]  

  • 60. Bisphosphonates inhibit stromelysin-1 (MMP-3), matrix metalloelastase (MMP-12), collagenase-3 (MMP-13) and enamelysin (MMP-20), but not urokinase-type plasminogen activator, and diminish invasion and migration of human malignant and endothelial cell lines.
    Heikkilä P; Teronen O; Moilanen M; Konttinen YT; Hanemaaijer R; Laitinen M; Maisi P; van der Pluijm G; Bartlett JD; Salo T; Sorsa T
    Anticancer Drugs; 2002 Mar; 13(3):245-54. PubMed ID: 11984068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.